For example, in a study of Texh cells in liver cancer and melanoma,59, 79 novel markers such as MYO7A, WARS, CXCL13, TOX, LAYN, PHLDA1, and SNAP47 were identified alongside well‐known Texh genes such as HAVCR2, PDCD1, ENTPD1 (CD39), CTLA4, TIGIT, TNFRSF9, and CD27. Some of these newly identified marker genes were further shown to regulate the function or the development of CD8+ Texh cells. This evidence concerns the gene ENTPD1 and melanoma.